Cha-Soon Kim

Title: Cha-Soon Kim: Innovator in Human Interferon Alpha Production

Introduction

Cha-Soon Kim is a notable inventor based in Yongin-shi, South Korea. He has made significant contributions to the field of biotechnology, particularly in the production of human interferon alpha. His innovative work has implications for therapeutic applications in various medical conditions.

Latest Patents

Cha-Soon Kim holds a patent for an "Expression and secretion vector for human interferon alpha and process for producing human interferon alpha by employing same." This invention discloses an expression vector designed for the secretive production of human interferon alpha (hIFNα). The vector comprises a polynucleotide encoding a modified thermostable enterotoxin II signal sequence and a polynucleotide encoding hIFNα ligated to the 3'-end. The process involves culturing a transformed microorganism capable of secreting a soluble form of active hIFNα into the periplasm of a cell, which does not contain an additional methionine residue at its N-terminal.

Career Highlights

Cha-Soon Kim is currently associated with Hanmi Pharmaceutical Co., Ltd., where he continues to advance his research and development efforts. His work has been instrumental in enhancing the efficiency of producing therapeutic proteins, which are crucial for treating various diseases.

Collaborations

Some of his notable coworkers include Se-Chang Kwon and Sung-Youb Jung. Their collaborative efforts have contributed to the success of their projects and the advancement of biotechnological innovations.

Conclusion

Cha-Soon Kim's contributions to the field of biotechnology, particularly in the production of human interferon alpha, highlight his role as an innovator. His patent and ongoing work at Hanmi Pharmaceutical Co., Ltd. demonstrate his commitment to advancing medical science.